Related Experiment Video
Updated: Apr 26, 2026
09:56
Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
Published on: July 27, 2014
12.0K
Differentiated NSC-34 cells as an in vitro cell model for VX
Baishali Kanjilal1, Brian M Keyser, Devon K Andres
1Pharmacology and Immunology Branch, U.S. Army Medical Research Institute of Chemical Defense , MD , USA and.
Toxicology Mechanisms and Methods
|July 22, 2014
Summary
Developing effective nerve agent (NA) therapeutics is crucial. This study shows differentiated NSC-34 cells are a viable in vitro model for screening NA antidotes by responding to VX exposure.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- The US military prioritizes developing nerve agent (NA) therapeutics.
- Current drug screening is limited by a lack of effective in vitro cellular models.
Purpose of the Study:
- To evaluate differentiated NSC-34 cells as an in vitro model for screening NA therapeutics.
- To investigate VX-induced apoptosis in NSC-34 cells.
Main Methods:
- Exposure of differentiated NSC-34 cells to VX (10-100 nM).
- Measurement of caspase-3 and caspase-9 activity.
- Annexin V/propidium iodide flow cytometry for cell death analysis.
- Assessment of pralidoxime (2-PAM) and MK-801 effects.
Main Results:
- VX exposure induced dose- and time-dependent increases in caspase-3 activity (maximal at 20h).
- Caspase-9 activity was elevated across all tested VX concentrations.
- VX-induced cell death was confirmed via flow cytometry.
- Pralidoxime (2-PAM) and MK-801 reduced VX-induced caspase activity.
Conclusions:
- Differentiated NSC-34 cells exhibit sensitivity to VX-induced apoptosis.
- These cells represent a promising in vitro model for screening novel NA antidotes.
